These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 30066948)
21. MicroRNA-421 confers paclitaxel resistance by binding to the KEAP1 3'UTR and predicts poor survival in non-small cell lung cancer. Duan FG; Wang MF; Cao YB; Dan Li ; Li RZ; Fan XX; Khan I; Lai HL; Zhang YZ; Hsiao WW; Yao XJ; Wu QB; Liu L; Tang YJ; Leung EL Cell Death Dis; 2019 Oct; 10(11):821. PubMed ID: 31659154 [TBL] [Abstract][Full Text] [Related]
22. MicroRNA-27b reverses docetaxel resistance of non-small cell lung carcinoma cells via targeting epithelial growth factor receptor. Chen S; Wang Q; Zhou XM; Zhu JP; Li T; Huang M Mol Med Rep; 2016 Jul; 14(1):949-54. PubMed ID: 27221512 [TBL] [Abstract][Full Text] [Related]
23. miR-339-5p downregulation contributes to Taxol resistance in small-cell lung cancer by targeting α1,2-fucosyltransferase 1. Gan CZ; Li G; Luo QS; Li HM IUBMB Life; 2017 Nov; 69(11):841-849. PubMed ID: 28940895 [TBL] [Abstract][Full Text] [Related]
24. FOXP4 modulates tumor growth and independently associates with miR-138 in non-small cell lung cancer cells. Yang T; Li H; Thakur A; Chen T; Xue J; Li D; Chen M Tumour Biol; 2015 Sep; 36(10):8185-91. PubMed ID: 25994569 [TBL] [Abstract][Full Text] [Related]
25. Shikonin suppresses NEAT1 and Akt signaling in treating paclitaxel-resistant non-small cell of lung cancer. Zang F; Rao Y; Zhu X; Wu Z; Jiang H Mol Med; 2020 Apr; 26(1):28. PubMed ID: 32268876 [TBL] [Abstract][Full Text] [Related]
26. Overexpression of miR-664 is associated with enhanced osteosarcoma cell migration and invasion ability via targeting SOX7. Bao Y; Chen B; Wu Q; Hu K; Xi X; Zhu W; Zhong X; Chen J Clin Exp Med; 2017 Feb; 17(1):51-58. PubMed ID: 26515813 [TBL] [Abstract][Full Text] [Related]
27. Autophagy regulates resistance of non-small cell lung cancer cells to paclitaxel. Chen K; Shi W Tumour Biol; 2016 Aug; 37(8):10539-44. PubMed ID: 26852748 [TBL] [Abstract][Full Text] [Related]
28. NEAT1 mediates paclitaxel-resistance of non-small cell of lung cancer through activation of Akt/mTOR signalling pathway. Li B; Gu W; Zhu X J Drug Target; 2019 Dec; 27(10):1061-1067. PubMed ID: 30782035 [TBL] [Abstract][Full Text] [Related]
29. Curcumin inhibits cell proliferation and induces apoptosis of human non-small cell lung cancer cells through the upregulation of miR-192-5p and suppression of PI3K/Akt signaling pathway. Jin H; Qiao F; Wang Y; Xu Y; Shang Y Oncol Rep; 2015 Nov; 34(5):2782-9. PubMed ID: 26351877 [TBL] [Abstract][Full Text] [Related]
30. MicroRNA-106a confers cisplatin resistance in non-small cell lung cancer A549 cells by targeting adenosine triphosphatase-binding cassette A1. Ma Y; Li X; Cheng S; Wei W; Li Y Mol Med Rep; 2015 Jan; 11(1):625-32. PubMed ID: 25339370 [TBL] [Abstract][Full Text] [Related]
31. microRNA miR-10b inhibition reduces cell proliferation and promotes apoptosis in non-small cell lung cancer (NSCLC) cells. Huang J; Sun C; Wang S; He Q; Li D Mol Biosyst; 2015 Jul; 11(7):2051-9. PubMed ID: 25988292 [TBL] [Abstract][Full Text] [Related]
32. miR-24-3p promotes cell migration and proliferation in lung cancer by targeting SOX7. Yan L; Ma J; Zhu Y; Zan J; Wang Z; Ling L; Li Q; Lv J; Qi S; Cao Y; Liu Y; Cao L; Zhang Y; Qi Z; Nie L J Cell Biochem; 2018 May; 119(5):3989-3998. PubMed ID: 29231262 [TBL] [Abstract][Full Text] [Related]
33. MiR-182 inhibits the epithelial to mesenchymal transition and metastasis of lung cancer cells by targeting the Met gene. Li Y; Zhang H; Li Y; Zhao C; Fan Y; Liu J; Li X; Liu H; Chen J Mol Carcinog; 2018 Jan; 57(1):125-136. PubMed ID: 28940757 [TBL] [Abstract][Full Text] [Related]
34. A novel pathway in NSCLC cells: miR‑191, targeting NFIA, is induced by chronic hypoxia, and promotes cell proliferation and migration. Zhao J; Qiao CR; Ding Z; Sheng YL; Li XN; Yang Y; Zhu DY; Zhang CY; Liu DL; Wu K; Zhao S Mol Med Rep; 2017 Mar; 15(3):1319-1325. PubMed ID: 28075452 [TBL] [Abstract][Full Text] [Related]
35. miR-1238 inhibits cell proliferation by targeting LHX2 in non-small cell lung cancer. Shi X; Zhan L; Xiao C; Lei Z; Yang H; Wang L; Zhao J; Zhang HT Oncotarget; 2015 Aug; 6(22):19043-54. PubMed ID: 26189214 [TBL] [Abstract][Full Text] [Related]
36. MiR-320a-3p/ELF3 axis regulates cell metastasis and invasion in non-small cell lung cancer via PI3K/Akt pathway. Zhao W; Sun Q; Yu Z; Mao S; Jin Y; Li J; Jiang Z; Zhang Y; Chen M; Chen P; Chen D; Xu H; Ding S; Yu Z Gene; 2018 Sep; 670():31-37. PubMed ID: 29803922 [TBL] [Abstract][Full Text] [Related]
37. microRNA-381 suppresses the growth and increases cisplatin sensitivity in non-small cell lung cancer cells through inhibition of nuclear factor-κB signaling. Huang RS; Zheng YL; Zhao J; Chun X Biomed Pharmacother; 2018 Feb; 98():538-544. PubMed ID: 29287202 [TBL] [Abstract][Full Text] [Related]
38. microRNA-338-3p functions as a tumor suppressor in human non‑small‑cell lung carcinoma and targets Ras-related protein 14. Sun J; Feng X; Gao S; Xiao Z Mol Med Rep; 2015 Feb; 11(2):1400-6. PubMed ID: 25374067 [TBL] [Abstract][Full Text] [Related]
39. Downregulation of microRNA-21 expression restrains non-small cell lung cancer cell proliferation and migration through upregulation of programmed cell death 4. Yang Y; Meng H; Peng Q; Yang X; Gan R; Zhao L; Chen Z; Lu J; Meng QH Cancer Gene Ther; 2015 Jan; 22(1):23-9. PubMed ID: 25477028 [TBL] [Abstract][Full Text] [Related]
40. Downregulation of miR-25 modulates non-small cell lung cancer cells by targeting CDC42. Yang T; Chen T; Li Y; Gao L; Zhang S; Wang T; Chen M Tumour Biol; 2015 Mar; 36(3):1903-11. PubMed ID: 25432132 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]